Regulation of Brain-Derived Neurotrophic Factor Exocytosis and Gamma-Aminobutyric Acidergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1

Biological Psychiatry

Volumn 80, Issue 4, 2016, Pages 312-322

  Yuan, Qiang ^a   Yang, Feng ^b   Xiao, Yixin ^a   Tan, Shawn ^a   Husain, Nilofer ^a   Ren, Ming ^b   Hu, Zhonghua ^b   Martinowich, Keri ^b   Ng, Julia S ^a   Kim, Paul J ^a   Han, Weiping ^c   Nagata, Koh ichi ^d   Weinberger, Daniel R ^b   Je, H Shawn ^a,e  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c AGENCY FOR SCIENCE   (Singapore)

^d INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Brain derived neurotrophic factor (BDNF); DTNBP1; Dysbindin 1; Exocytosis; Gamma aminobutyric acid (GABA); Interneuron synapse; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DYSBINDIN; 4 AMINOBUTYRIC ACID; DTNBP1 PROTEIN, HUMAN; DYSTROPHIN ASSOCIATED PROTEIN; POTASSIUM; SMALL INTERFERING RNA; VESICULAR INHIBITORY AMINO ACID TRANSPORTER; VIAAT PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL CULTURE; BRAIN SLICE; CONTROLLED STUDY; EMBRYO; EXOCYTOSIS; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INTERNEURON; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SLICE CULTURE; SYNAPSE; WHOLE CELL PATCH CLAMP; ANIMAL; BRAIN CORTEX; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; MAMMALIAN EMBRYO; METABOLISM; MUTATION; ORGAN CULTURE TECHNIQUE; SYNAPTIC POTENTIAL; TRANSFORMED CELL LINE;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE, TRANSFORMED; CELLS, CULTURED; CEREBRAL CORTEX; DYSTROPHIN-ASSOCIATED PROTEINS; EMBRYO, MAMMALIAN; EXOCYTOSIS; GAMMA-AMINOBUTYRIC ACID; HUMANS; INTERNEURONS; MUTATION; ORGAN CULTURE TECHNIQUES; POTASSIUM; RATS; RNA, SMALL INTERFERING; SYNAPSES; SYNAPTIC POTENTIALS; VESICULAR INHIBITORY AMINO ACID TRANSPORT PROTEINS;

EID: 84941772941     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.08.019     Document Type: Article

References (70)

1. 1 Cline, H., Synaptogenesis: A balancing act between excitation and inhibition. Curr Biol 15 (2005), R203–R205.
2. 2 DeFelipe, J., Neocortical neuronal diversity: Chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell surface molecules. Cereb Cortex 3 (1993), 273–289.
3. 3 Nakazawa, K., Zsiros, V., Jiang, Z., Nakao, K., Kolata, S., Zhang, S., Belforte, J.E., GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 62 (2012), 1574–1583.
4. 4 Lewis, D.A., Hashimoto, T., Volk, D.W., Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6 (2005), 312–324.
5. 5 McGrath, J., Saha, S., Chant, D., Welham, J., Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30 (2008), 67–76.
6. 6 Akbarian, S., Huang, H.S., Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 52 (2006), 293–304.
7. 7 Gonzalez-Burgos, G., Hashimoto, T., Lewis, D.A., Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep 12 (2010), 335–344.
8. 8 Straub, R.E., Jiang, Y., MacLean, C.J., Ma, Y., Webb, B.T., Myakishev, M.V., et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71 (2002), 337–348.
9. 9 Riley, B., Kuo, P.H., Maher, B.S., Fanous, A.H., Sun, J., Wormley, B., et al. The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr Res 115 (2009), 245–253.
10. 10 Ayalew, M., Le-Niculescu, H., Levey, D.F., Jain, N., Changala, B., Patel, S.D., et al. Convergent functional genomics of schizophrenia: From comprehensive understanding to genetic risk prediction. Mol Psychiatry 17 (2012), 887–905.
11. 11 Talbot, K., Ong, W.Y., Blake, D.J., Tang, J., Louneva, N., Carlson, G.C., et al. Dysbindin-1 and its protein family. Lajtha, A., Javitt, D., Kantrowitz, J., (eds.) Handbook of Neurochemistry and Molecular Neurobiology, 2009, Springer, New York, 107–241.
12. 12 Talbot, K., Cho, D.S., Ong, W.Y., Benson, M.A., Han, L.Y., Kazi, H.A., et al. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum Mol Genet 15 (2006), 3041–3054.
13. 13 Talbot, K., Eidem, W.L., Tinsley, C.L., Benson, M.A., Thompson, E.W., Smith, R.J., et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 113 (2004), 1353–1363.
14. 14 Weickert, C.S., Rothmond, D.A., Hyde, T.M., Kleinman, J.E., Straub, R.E., Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr Res 98 (2008), 105–110.
15. 15 Tang, J., LeGros, R.P., Louneva, N., Yeh, L., Cohen, J.W., Hahn, C.G., et al. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. Hum Mol Genet 18 (2009), 3851–3863.
16. 16 Karlsgodt, K.H., Robleto, K., Trantham-Davidson, H., Jairl, C., Cannon, T.D., Lavin, A., Jentsch, J.D., Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance. Biol Psychiatry 69 (2011), 28–34.
17. 17 Jentsch, J.D., Trantham-Davidson, H., Jairl, C., Tinsley, M., Cannon, T.D., Lavin, A., Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice. Neuropsychopharmacology 34 (2009), 2601–2608.
18. 18 Talbot, K., The sandy (sdy) mouse: A dysbindin-1 mutant relevant to schizophrenia research. Prog Brain Res 179 (2009), 87–94.
19. 19 Carlson, G.C., Talbot, K., Halene, T.B., Gandal, M.J., Kazi, H.A., Schlosser, L., et al. Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia. Proc Natl Acad Sci U S A 108 (2011), E962–E970.
20. 20 Ji, Y., Yang, F., Papaleo, F., Wang, H.X., Gao, W.J., Weinberger, D.R., Lu, B., Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc Natl Acad Sci U S A 106 (2009), 19593–19598.
21. 21 Papaleo, F., Yang, F., Garcia, S., Chen, J., Lu, B., Crawley, J.N., Weinberger, D.R., Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry 17 (2012), 85–98.
22. 22 Wang, H., Yuan, Y., Zhang, Z., Yan, H., Feng, Y., Li, W., Dysbindin-1C is required for the survival of hilar mossy cells and the maturation of adult newborn neurons in dentate gyrus. J Biol Chem 289 (2014), 29060–29072.
23. 23 Yamada, M.K., Nakanishi, K., Ohba, S., Nakamura, T., Ikegaya, Y., Nishiyama, N., Matsuki, N., Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. J Neurosci 22 (2002), 7580–7585.
24. 24 Kohara, K., Kitamura, A., Morishima, M., Tsumoto, T., Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science 291 (2001), 2419–2423.
25. 25 Woo, N.H., Lu, B., Regulation of cortical interneurons by neurotrophins: From development to cognitive disorders. Neuroscientist 12 (2006), 43–56.
26. 26 Kohara, K., Kitamura, A., Adachi, N., Nishida, M., Itami, C., Nakamura, S., Tsumoto, T., Inhibitory but not excitatory cortical neurons require presynaptic brain-derived neurotrophic factor for dendritic development, as revealed by chimera cell culture. J Neurosci 23 (2003), 6123–6131.
27. 27 Kohara, K., Yasuda, H., Huang, Y., Adachi, N., Sohya, K., Tsumoto, T., A local reduction in cortical GABAergic synapses after a loss of endogenous brain-derived neurotrophic factor, as revealed by single-cell gene knock-out method. J Neurosci 27 (2007), 7234–7244.
28. 28 Ito, H., Morishita, R., Shinoda, T., Iwamoto, I., Sudo, K., Okamoto, K., Nagata, K., Dysbindin-1, WAVE2 and Abi-1 form a complex that regulates dendritic spine formation. Mol Psychiatry 15 (2010), 976–986.
29. 29 Mabb, A.M., Je, H.S., Wall, M.J., Robinson, C.G., Larsen, R.S., Qiang, Y., et al. Triad3A regulates synaptic strength by ubiquitination of Arc. Neuron 82 (2014), 1299–1316.
30. 30 Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., et al. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 503 (2013), 267–271.
31. 31 Gokhale, A., Larimore, J., Werner, E., So, L., Moreno-De-Luca, A., Lese-Martin, C., et al. Quantitative proteomic and genetic analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of the biogenesis of lysosome-related organelles complex 1. J Neurosci 32 (2012), 3697–3711.
32. 32 Larimore, J., Tornieri, K., Ryder, P.V., Gokhale, A., Zlatic, S.A., Craige, B., et al. The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapse. Mol Biol Cell 22 (2011), 4854–4867.
33. 33 Mead, C.L., Kuzyk, M.A., Moradian, A., Wilson, G.M., Holt, R.A., Morin, G.B., Cytosolic protein interactions of the schizophrenia susceptibility gene dysbindin. J Neurochem 113 (2010), 1491–1503.
34. 34 Autry, A.E., Monteggia, L.M., Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64 (2012), 238–258.
35. 35 Rocamora, N., Pascual, M., Acsady, L., de Lecea, L., Freund, T.F., Soriano, E., Expression of NGF and NT3 mRNAs in hippocampal interneurons innervated by the GABAergic septohippocampal pathway. J Neurosci 16 (1996), 3991–4004.
36. 36 Miesenbock, G., De Angelis, D.A., Rothman, J.E., Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 394 (1998), 192–195.
37. 37 Merrifield, C.J., Perrais, D., Zenisek, D., Coupling between clathrin-coated-pit invagination, cortactin recruitment, and membrane scission observed in live cells. Cell 121 (2005), 593–606.
38. 38 Kennedy, M.J., Davison, I.G., Robinson, C.G., Ehlers, M.D., Syntaxin-4 defines a domain for activity-dependent exocytosis in dendritic spines. Cell 141 (2010), 524–535.
39. 39 Matsuda, N., Lu, H., Fukata, Y., Noritake, J., Gao, H., Mukherjee, S., et al. Differential activity-dependent secretion of brain-derived neurotrophic factor from axon and dendrite. J Neurosci 29 (2009), 14185–14198.
40. 40 Lee, S.J., Escobedo-Lozoya, Y., Szatmari, E.M., Yasuda, R., Activation of CaMKII in single dendritic spines during long-term potentiation. Nature 458 (2009), 299–304.
41. 41 Feng, Y.Q., Zhou, Z.Y., He, X., Wang, H., Guo, X.L., Hao, C.J., et al. Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia. Schizophr Res 106 (2008), 218–228.
42. 42 Hattori, S., Murotani, T., Matsuzaki, S., Ishizuka, T., Kumamoto, N., Takeda, M., et al. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem Biophys Res Commun 373 (2008), 298–302.
43. 43 Chen, X.W., Feng, Y.Q., Hao, C.J., Guo, X.L., He, X., Zhou, Z.Y., et al. DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release. J Cell Biol 181 (2008), 791–801.
44. 44 Lu, B., Je, H.S., Neurotrophic regulation of the development and function of the neuromuscular synapses. J Neurocytol 32 (2003), 931–941.
45. 45 Lu, B., Woo, N.H., Trophic factors in synaptic plasticity and memory. Albright, T., Bloom, F., Gage, F., Spitzer, N., Squire, L., (eds.) New Encyclopedia of Neuroscience, 2006, Elsevier, New York.
46. 46 Konopaske, G.T., Sweet, R.A., Wu, Q., Sampson, A., Lewis, D.A., Regional specificity of chandelier neuron axon terminal alterations in schizophrenia. Neuroscience 138 (2006), 189–196.
47. 47 Jones, K.R., Farinas, I., Backus, C., Reichardt, L.F., Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76 (1994), 989–999.
48. 48 Altar, C.A., Boylan, C.B., Fritsche, M., Jackson, C., Hyman, C., Lindsay, R.M., The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. Exp Neurol 130 (1994), 31–40.
49. 49 Huang, Z.J., Kirkwood, A., Pizzorusso, T., Porciatti, V., Morales, B., Bear, M.F., et al. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98 (1999), 739–755.
50. 50 Aguado, F., Carmona, M.A., Pozas, E., Aguilo, A., Martinez-Guijarro, F.J., Alcantara, S., et al. BDNF regulates spontaneous correlated activity at early developmental stages by increasing synaptogenesis and expression of the K+/Cl- co-transporter KCC2. Development 130 (2003), 1267–1280.
51. 51 Berghuis, P., Dobszay, M.B., Sousa, K.M., Schulte, G., Mager, P.P., Hartig, W., et al. Brain-derived neurotrophic factor controls functional differentiation and microcircuit formation of selectively isolated fast-spiking GABAergic interneurons. Eur J Neurosci 20 (2004), 1290–1306.
52. 52 Ernfors, P., Wetmore, C., Olson, L., Persson, H., Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 5 (1990), 511–526.
53. 53 Dean, C., Liu, H., Staudt, T., Stahlberg, M.A., Vingill, S., Buckers, J., et al. Distinct subsets of Syt-IV/BDNF vesicles are sorted to axons versus dendrites and recruited to synapses by activity. J Neurosci 32 (2012), 5398–5413.
54. 54 Dean, C., Liu, H., Dunning, F.M., Chang, P.Y., Jackson, M.B., Chapman, E.R., Synaptotagmin-IV modulates synaptic function and long-term potentiation by regulating BDNF release. Nat Neurosci 12 (2009), 767–776.
55. 55 Shinoda, Y., Sadakata, T., Nakao, K., Katoh-Semba, R., Kinameri, E., Furuya, A., et al. Calcium-dependent activator protein for secretion 2 (CAPS2) promotes BDNF secretion and is critical for the development of GABAergic interneuron network. Proc Natl Acad Sci U S A 108 (2011), 373–378.
56. 56 Larimore, J., Zlatic, S.A., Gokhale, A., Tornieri, K., Singleton, K.S., Mullin, A.P., et al. Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes. J Biol Chem 289 (2014), 14291–14300.
57. 57 Li, W., Zhang, Q., Oiso, N., Novak, E.K., Gautam, R., O'Brien, E.P., et al. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet 35 (2003), 84–89.
58. 58 Taneichi-Kuroda, S., Taya, S., Hikita, T., Fujino, Y., Kaibuchi, K., Direct interaction of dysbindin with the AP-3 complex via its mu subunit. Neurochem Int 54 (2009), 431–438.
59. 59 Asensio, C.S., Sirkis, D.W., Edwards, R.H., RNAi screen identifies a role for adaptor protein AP-3 in sorting to the regulated secretory pathway. J Cell Biol 191 (2010), 1173–1187.
60. 60 Kantheti, P., Qiao, X., Diaz, M.E., Peden, A.A., Meyer, G.E., Carskadon, S.L., et al. Mutation in AP-3 delta in the mocha mouse links endosomal transport to storage deficiency in platelets, melanosomes, and synaptic vesicles. Neuron 21 (1998), 111–122.
61. 61 Nakatsu, F., Okada, M., Mori, F., Kumazawa, N., Iwasa, H., Zhu, G., et al. Defective function of GABA-containing synaptic vesicles in mice lacking the AP-3B clathrin adaptor. J Cell Biol 167 (2004), 293–302.
62. 62 Larimore, J., Ryder, P.V., Kim, K.Y., Ambrose, L.A., Chapleau, C., Calfa, G., et al. MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons. PLoS One, 8, 2013, e65069.
63. 63 Talbot, K., Louneva, N., Cohen, J.W., Kazi, H., Blake, D.J., Arnold, S.E., Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location. PLoS One, 6, 2011, e16886.
64. 64 Lewis, D.A., Gonzalez-Burgos, G., Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33 (2008), 141–165.
65. 65 Goldman-Rakic, P.S., Cellular basis of working memory. Neuron 14 (1995), 477–485.
66. 66 Le Magueresse, C., Monyer, H., GABAergic interneurons shape the functional maturation of the cortex. Neuron 77 (2013), 388–405.
67. 67 Weickert, C.S., Ligons, D.L., Romanczyk, T., Ungaro, G., Hyde, T.M., Herman, M.M., et al. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry 10 (2005), 637–650.
68. 68 Longo, F.M., Yang, T., Knowles, J.K., Xie, Y., Moore, L.A., Massa, S.M., Small molecule neurotrophin receptor ligands: Novel strategies for targeting Alzheimer's disease mechanisms. Curr Alzheimer Res 4 (2007), 503–506.
69. 69 Price, R.D., Milne, S.A., Sharkey, J., Matsuoka, N., Advances in small molecules promoting neurotrophic function. Pharmacol Ther 115 (2007), 292–306.
70. 70 Nestler, E.J., Hyman, S.E., Animal models of neuropsychiatric disorders. Nat Neurosci 13 (2010), 1161–1169.